Pfizer intends to sell US $ 54,000 million in vaccines and anticovid pills in 2022
After obtaining generous profits from its vaccine against covid-19, the American laboratory Pfizer plans to sell US$ 32,000 million of that drug this year and US$ 22,000 million for its treatment against